Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,dividendsPaid,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,gmtOffSetMilliseconds,esgPopulated,tradeable,market,exchange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,priceHint,marketState,exchangeDataDelayedBy,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry,address2
t0,FSPKF,1440900000,576356992,36050000,,202600000,,149350000,104250000,341850000,201550000,201550000,,-1300000,,,,53250000,530500000,328950000,188650000,1050000,,149350000,149350000,80000000,554100000,1520900000,256200000,2075000000,249100000,42900000,1029200000,33900000,242600000,192900000,97300000,427500000,81300000,500000,242600000,882100000,920000000,280300000,228900000,63700000,270600000,56700000,-107600000,13700000,-152700000,-2450000,-47550000,1000000,3100000,-250000,203600000,21750000,-43911781,-18500000,4500000,30550000,-40900000,492500000,en-US,US,EQUITY,False,Delayed Quote,USD,-1.665658,22.63 - 22.67,23.054,0.0,0.0,0,0,finmb_875015,Other OTC,Fisher & Paykel Healthcare Corporation Limited,NZD,1015,4016,-14400000,False,False,us_market,PNK,0.485,2.127,22.304445,0.3655548,0.016389325,22.652899,0.017101288,0.0007549271,12799686656,10.658204,15,America/New_York,EDT,22.67,1630512532,-0.38400078,22.67,22.67,22.63,659,FISHER & PAYKEL HEALTHCARE CORP,2,POST,0,3.0599995,0.1560428,19.61 - 26.46,-3.789999,-0.14323504,19.61,26.46,0.315,46.742268,0.013663572,-0.16,,,26.46,19.61,22.3,22.65,1.01k,4.02k,576.36M,,574.22M,5.39%,28.52%,,,,,,0.27,1.20%,0.31,1.37%,1.67,34.85%,,"Jun 23, 2021",,,"Mar 30, 2021","Mar 30, 2021",26.59%,36.13%,25.37%,42.03%,1.97B,3.42,53.10%,1.25B,781.3M,524.2M,0.49,79.80%,377.6M,0.65,119.8M,7.88,2.15,2.13,625.3M,340.26M,Value,2013,Healthcare,5788,8,10,"Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.",Auckland,64 9 574 0100,5,1640908800,1622505600,3,New Zealand,http://www.fphcare.com,86400,5,15 Maurice Paykel Place,64 9 574 0158,Medical Instruments & Supplies,East Tamaki
t-1,FSPKF,1440900000,576356992,36050000,,202600000,,149350000,104250000,341850000,201550000,201550000,,-1300000,,,,53250000,530500000,328950000,188650000,1050000,,149350000,149350000,80000000,554100000,1520900000,256200000,2075000000,249100000,42900000,1029200000,33900000,242600000,192900000,97300000,427500000,81300000,500000,242600000,882100000,920000000,280300000,228900000,63700000,270600000,56700000,-107600000,13700000,-152700000,-2450000,-47550000,1000000,3100000,-250000,203600000,21750000,-43911781,-18500000,4500000,30550000,-40900000,492500000,en-US,US,EQUITY,False,Delayed Quote,USD,-1.665658,22.63 - 22.67,23.054,0.0,0.0,0,0,finmb_875015,Other OTC,Fisher & Paykel Healthcare Corporation Limited,NZD,1015,4016,-14400000,False,False,us_market,PNK,0.485,2.127,22.304445,0.3655548,0.016389325,22.652899,0.017101288,0.0007549271,12799686656,10.658204,15,America/New_York,EDT,22.67,1630512532,-0.38400078,22.67,22.67,22.63,659,FISHER & PAYKEL HEALTHCARE CORP,2,POST,0,3.0599995,0.1560428,19.61 - 26.46,-3.789999,-0.14323504,19.61,26.46,0.315,46.742268,0.013663572,-0.16,,,26.46,19.61,22.3,22.65,1.01k,4.02k,576.36M,,574.22M,5.39%,28.52%,,,,,,0.27,1.20%,0.31,1.37%,1.67,34.85%,,"Jun 23, 2021",,,"Mar 30, 2021","Mar 30, 2021",26.59%,36.13%,25.37%,42.03%,1.97B,3.42,53.10%,1.25B,781.3M,524.2M,0.49,79.80%,377.6M,0.65,119.8M,7.88,2.15,2.13,625.3M,340.26M,Value,2013,Healthcare,5788,8,10,"Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.",Auckland,64 9 574 0100,5,1640908800,1622505600,3,New Zealand,http://www.fphcare.com,86400,5,15 Maurice Paykel Place,64 9 574 0158,Medical Instruments & Supplies,East Tamaki
t-2,FSPKF,1144200000,576356992,32300000,,156500000,,112750000,94050000,280950000,154600000,154600000,,-1200000,,,,43750000,455100000,300500000,174150000,1900000,,112750000,112750000,78900000,408600000,1223100000,69600000,1631700000,244800000,11500000,822700000,32500000,155600000,132700000,93200000,336100000,66600000,45500000,155600000,777000000,643100000,65100000,239700000,20700000,233600000,196700000,6300000,19150000,-40950000,-2650000,-46450000,750000,21400000,-250000,109050000,18500000,-36688219,-43550000,-7050000,9250000,-39200000,307000000,en-US,US,EQUITY,False,Delayed Quote,USD,-1.665658,22.63 - 22.67,23.054,0.0,0.0,0,0,finmb_875015,Other OTC,Fisher & Paykel Healthcare Corporation Limited,NZD,1015,4016,-14400000,False,False,us_market,PNK,0.485,2.127,22.304445,0.3655548,0.016389325,22.652899,0.017101288,0.0007549271,12799686656,10.658204,15,America/New_York,EDT,22.67,1630512532,-0.38400078,22.67,22.67,22.63,659,FISHER & PAYKEL HEALTHCARE CORP,2,POST,0,3.0599995,0.1560428,19.61 - 26.46,-3.789999,-0.14323504,19.61,26.46,0.315,46.742268,0.013663572,-0.16,,,26.46,19.61,22.3,22.65,1.01k,4.02k,576.36M,,574.22M,5.39%,28.52%,,,,,,0.27,1.20%,0.31,1.37%,1.67,34.85%,,"Jun 23, 2021",,,"Mar 30, 2021","Mar 30, 2021",26.59%,36.13%,25.37%,42.03%,1.97B,3.42,53.10%,1.25B,781.3M,524.2M,0.49,79.80%,377.6M,0.65,119.8M,7.88,2.15,2.13,625.3M,340.26M,Value,2013,Healthcare,5788,8,10,"Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.",Auckland,64 9 574 0100,5,1640908800,1622505600,3,New Zealand,http://www.fphcare.com,86400,5,15 Maurice Paykel Place,64 9 574 0158,Medical Instruments & Supplies,East Tamaki
t-3,FSPKF,1144200000,576356992,32300000,,156500000,,112750000,94050000,280950000,154600000,154600000,,-1200000,,,,43750000,455100000,300500000,174150000,1900000,,112750000,112750000,78900000,408600000,1223100000,69600000,1631700000,244800000,11500000,822700000,32500000,155600000,132700000,93200000,336100000,66600000,45500000,155600000,777000000,643100000,65100000,239700000,20700000,233600000,196700000,6300000,19150000,-40950000,-2650000,-46450000,750000,21400000,-250000,109050000,18500000,-36688219,-43550000,-7050000,9250000,-39200000,307000000,en-US,US,EQUITY,False,Delayed Quote,USD,-1.665658,22.63 - 22.67,23.054,0.0,0.0,0,0,finmb_875015,Other OTC,Fisher & Paykel Healthcare Corporation Limited,NZD,1015,4016,-14400000,False,False,us_market,PNK,0.485,2.127,22.304445,0.3655548,0.016389325,22.652899,0.017101288,0.0007549271,12799686656,10.658204,15,America/New_York,EDT,22.67,1630512532,-0.38400078,22.67,22.67,22.63,659,FISHER & PAYKEL HEALTHCARE CORP,2,POST,0,3.0599995,0.1560428,19.61 - 26.46,-3.789999,-0.14323504,19.61,26.46,0.315,46.742268,0.013663572,-0.16,,,26.46,19.61,22.3,22.65,1.01k,4.02k,576.36M,,574.22M,5.39%,28.52%,,,,,,0.27,1.20%,0.31,1.37%,1.67,34.85%,,"Jun 23, 2021",,,"Mar 30, 2021","Mar 30, 2021",26.59%,36.13%,25.37%,42.03%,1.97B,3.42,53.10%,1.25B,781.3M,524.2M,0.49,79.80%,377.6M,0.65,119.8M,7.88,2.15,2.13,625.3M,340.26M,Value,2013,Healthcare,5788,8,10,"Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.",Auckland,64 9 574 0100,5,1640908800,1622505600,3,New Zealand,http://www.fphcare.com,86400,5,15 Maurice Paykel Place,64 9 574 0158,Medical Instruments & Supplies,East Tamaki
